Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells
- PMID: 9583742
- DOI: 10.3109/08916939809008041
Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells
Abstract
Insulin-dependent diabetes mellitus (IDDM) is caused by the progressive autoimmune destruction of insulin-producing pancreatic beta cells. Although the pathogenesis of autoimmune IDDM has been extensively studied, the precise mechanisms involved in the initiation and progression of beta cell destruction remain unclear. Animal models used in the study of IDDM, such as the BioBreeding (BB) rat and the nonobese diabetic (NOD) mouse, have greatly enhanced our understanding of the pathogenic mechanisms involved in this disease. In these animals, macrophages and/or dendritic cells are the first cell types to infiltrate the pancreatic islets. Macrophages must be involved in the pathogenesis of IDDM early on, since inactivation of macrophages results in the near-complete prevention of insulitis and diabetes in both NOD mice and BB rats. The presentation of beta cell-specific autoantigens by macrophages and/or dendritic cells to CD4+ T helper cells, in association with MHC class II molecules, is considered the initial step in the development of autoimmune IDDM. The activated macrophages secrete IL-12, which stimulates Th1 type CD4+ T cells. The CD4+ T cells secrete IFN-gamma and IL-2. IFN-gamma activates other resting macrophages, which, in turn, release cytokines, such as IL-1beta, TNF-alpha, and free radicals, which are toxic to beta cells. During this process, IL-2 and other cytokines induce the migration of CD8+ peripheral T cells to the inflamed islets, perhaps by inducing the expression of a specific homing receptor. The precytotoxic CD8+ T cells that bear beta cell-specific autoantigen receptors differentiate into cytotoxic effector T cells upon recognition of the beta cell-specific peptide bound to MHC class I molecules in the presence of beta cell-specific CD4+ T helper cells. The cytotoxic CD8+ T cells then effect beta cell damage by releasing perforin and granzyme, and by Fas-mediated apoptosis. In this way, macrophages, CD4+ T cells, and CD8+ T cells synergistically destroy beta cells, resulting in the onset of autoimmune IDDM.
Similar articles
-
Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.Ann N Y Acad Sci. 2001 Apr;928:200-11. doi: 10.1111/j.1749-6632.2001.tb05650.x. Ann N Y Acad Sci. 2001. PMID: 11795511 Review.
-
Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes.Arch Pharm Res. 1999 Oct;22(5):437-47. doi: 10.1007/BF02979150. Arch Pharm Res. 1999. PMID: 10549569 Review.
-
An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.Diabetes Metab Rev. 1998 Jun;14(2):129-51. doi: 10.1002/(sici)1099-0895(199806)14:2<129::aid-dmr208>3.0.co;2-v. Diabetes Metab Rev. 1998. PMID: 9679667 Review.
-
IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.J Immunol. 2003 Jun 1;170(11):5491-501. doi: 10.4049/jimmunol.170.11.5491. J Immunol. 2003. PMID: 12759426
-
Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.J Immunol. 2004 May 1;172(9):5714-21. doi: 10.4049/jimmunol.172.9.5714. J Immunol. 2004. PMID: 15100317
Cited by
-
Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.Clin Rev Allergy Immunol. 2017 Jun;52(3):460-472. doi: 10.1007/s12016-016-8587-y. Clin Rev Allergy Immunol. 2017. PMID: 27677500 Review.
-
Treating type-1 diabetes with an epigenetic drug.Elife. 2014 Dec 30;3:e05720. doi: 10.7554/eLife.05720. Elife. 2014. PMID: 25549298 Free PMC article.
-
Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats.Cancer Sci. 2007 Mar;98(3):294-8. doi: 10.1111/j.1349-7006.2007.00406.x. Cancer Sci. 2007. PMID: 17270018 Free PMC article.
-
Immunomodulation of the anti-islet CD8 T cell response by B7-2.J Clin Immunol. 2007 Mar;27(2):221-6. doi: 10.1007/s10875-006-9067-6. Epub 2007 Jan 23. J Clin Immunol. 2007. PMID: 17243007
-
Effect of Sanqi Oral Liquid on the expressions of CD4⁺, CD8⁺ and CD68⁺ cells in 5/6 nephrectomized rats with chronic renal failure.Chin J Integr Med. 2013 Aug;19(8):589-95. doi: 10.1007/s11655-012-1233-5. Epub 2012 Dec 3. Chin J Integr Med. 2013. PMID: 23212567
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous